Editas Medicine, Inc. - COM (EDIT)

Historical Portfolio Holders from Q1 2016 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
55M
Holdings value Q3 2024
$188M
Value change Q3 2024
-$7.61M
Grand Portfolio weight change Q3 2024
0%
Number of holders
222
Number of buys Q3 2024
97
Number of sells Q3 2024
-104
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 55M $188M -$7.61M $3.41 222
2024 Q2 56.4M $263M -$55.7M $4.67 230
2024 Q1 67.9M $504M +$62.9M $7.42 220
2023 Q4 58.8M $596M -$24.8M $10.13 222
2023 Q3 61.7M $481M -$15.3M $7.80 216
2023 Q2 62.8M $517M +$83.1M $8.23 231
2023 Q1 52.9M $384M -$13.7M $7.25 226
2022 Q4 54M $479M +$43.3M $8.87 241
2022 Q3 48.2M $590M +$8.78M $12.24 240
2022 Q2 47.5M $561M +$5.83M $11.83 233
2022 Q1 45.4M $862M -$138M $19.02 237
2021 Q4 50.9M $1.35B -$57.2M $26.55 287
2021 Q3 51.7M $2.12B -$9.9M $41.08 309
2021 Q2 52.1M $2.96B -$42.3M $56.64 310
2021 Q1 53.1M $2.23B -$37.1M $42.00 293
2020 Q4 52.9M $3.71B -$146M $70.11 306
2020 Q3 55.1M $1.55B +$15.8M $28.06 234
2020 Q2 54.2M $1.6B +$264M $29.58 224
2020 Q1 45.6M $904M -$9.12M $19.83 186
2019 Q4 45.8M $1.35B +$25.8M $29.61 219
2019 Q3 45M $1.02B +$118M $22.74 177
2019 Q2 39.7M $983M +$65.9M $24.74 186
2019 Q1 37.4M $915M +$73.8M $24.45 195
2018 Q4 34.5M $784M +$24.2M $22.75 186
2018 Q3 33.2M $1.06B +$37M $31.82 193
2018 Q2 32M $1.15B +$41M $35.83 210
2018 Q1 31M $1.03B +$24.6M $33.15 194
2017 Q4 30.2M $929M +$79.2M $30.73 147
2017 Q3 27.2M $653M +$40.3M $24.01 113
2017 Q2 25.8M $433M +$21.1M $16.78 107
2017 Q1 27.5M $614M +$121M $22.32 99
2016 Q4 23.5M $381M +$22.2M $16.23 83
2016 Q3 22.2M $299M +$9.01M $13.48 70
2016 Q2 17.6M $429M -$15.1M $24.40 65
2016 Q1 18.2M $625M +$464M $34.54 49